Wegovy 1 MG/0.5 ML pen 0.5ML
Ended Awarded Last action
- Contract number
- SPE2DR26FW3ZQ
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $20,764
Award facts
- Contract value 100% obligated
- $20,764.24 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 325411 Medicinal and Botanical Manufacturing
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a delivery order valued at $20,764.24 to AmerisourceBergen Drug Corp for Wegovy (semaglutide) 1 mg/0.5 mL pens on December 23, 2025, with completion scheduled for December 24, 2025. This competitively awarded, firm fixed-price delivery order represents a single-transaction procurement under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (designated SPE2DX). The contract is not subject to any small business set-aside designation. AmerisourceBergen, headquartered in Conshohocken, Pennsylvania, serves as a primary pharmaceutical distributor supporting federal medical procurement needs across the Defense Health Agency, U.S. Coast Guard, and other government healthcare systems.
This delivery order exemplifies AmerisourceBergen's role as a critical vendor within DLA's pharmaceutical supply chain, supplying specialty medications and brand-name drugs across multiple therapeutic domains to support military healthcare programs. The parent IDC, valued at $999,999,999.00 and extending through December 2026, provides a comprehensive global framework enabling flexible procurement of pharmaceutical products, medical supplies, vaccines, and related healthcare commodities. The award reflects ongoing federal procurement of specialty pharmaceutical products through competitive contracting mechanisms, with AmerisourceBergen demonstrating sustained capability to fulfill federal medical supply requirements across transaction values ranging from minimal to substantial orders.
Quick answers
Who was awarded contract SPE2DR26FW3ZQ?
SPE2DR26FW3ZQ was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on December 23, 2025.
How much is contract SPE2DR26FW3ZQ worth?
The government has obligated $20,764 on SPE2DR26FW3ZQ.
Is contract SPE2DR26FW3ZQ an order under another contract?
Yes. SPE2DR26FW3ZQ is a delivery order under SPE2DR25D7067, an indefinite delivery contract.
Was contract SPE2DR26FW3ZQ competed?
The extent of competition for SPE2DR26FW3ZQ was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award